Cancer Research CR  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ursin, G.
Right arrow Articles by Gentzschein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ursin, G.
Right arrow Articles by Gentzschein, E.
[Cancer Research 61, 3326-3329, April 15, 2001]
© 2001 American Association for Cancer Research


Epidemiology and Prevention

Do Urinary Estrogen Metabolites Reflect the Differences in Breast Cancer Risk between Singapore Chinese and United States African-American and White Women?1

Giske Ursin2, Melissa Wilson, Brian E. Henderson, Laurence N. Kolonel, Kristine Monroe, Hin-Peng Lee, Adeline Seow, Mimi C. Yu, Frank Z. Stanczyk and Elisabet Gentzschein

Department of Preventive Medicine [G. U., M. W., B. E. H., K. M., M. C. Y.], University of Southern California/Norris Comprehensive Cancer Center and Department of Obstetrics and Gynecology, University of Southern California/Los Angeles County Women’s Hospital [F. Z. S., E. G.], Los Angeles, California 90089; Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813 [L. N. K.]; and Department of Community, Occupational and Family Medicine, National University of Singapore, Singapore 117597 [H-P. L., A. S.]

Breast cancer risk is substantially lower in Singapore than in women from the United States. Part of the risk discrepancy is probably explained by differences in the production of endogenous estrogens, but differences in the pathway by which estrogen is metabolized may also play a role. We undertook a study to determine whether the ratio of urinary 2-hydroxyestrone (2OHE1):16{alpha}-hydroxyestrone (16{alpha}-OHE1) was higher in Singapore Chinese than in a group of United States (predominantly African-American) women living in Los Angeles. We also wanted to determine whether any difference in estrogen metabolite ratio between these two groups of women was greater than that in estrone (E1), estradiol (E2) and estriol (E3). The participants in this study were randomly selected healthy, non-estrogen using women participating in the Singapore Chinese Health Study (n = 67) or the Hawaii/Los Angeles Multiethnic Cohort Study (n = 58). After adjusting for age and age at menopause, mean urinary 2-OHE1 was only 23% (P = 0.03) higher in Singapore Chinese than in United States women, and there were no statistically significant differences in 16{alpha}-OHE1 levels or in the ratio of 2-OHE1:16{alpha}-OHE1 between the two groups. The adjusted mean 2-OHE1:16{alpha}-OHE1 ratio was 1.63 in Singapore Chinese and 1.48 in United States women (P = 0.41). In contrast, the adjusted mean values of E1, E2, and E3 were 162% (P < 0.0001), 152% (P < 0.0001), and 92% (P = 0.0009) higher, respectively, in United States women than in Singapore Chinese women. Our study suggests that urinary E1, E2, and E3 reflect the differences in breast cancer risk between Singapore Chinese and United States women to a stronger degree than the estrogen metabolites 2OHE1 and 16{alpha}-OHE1 or the ratio of 2OHE1:16{alpha}-OHE1.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Faupel-Badger, B. J. Fuhrman, X. Xu, R. T. Falk, L. K. Keefer, T. D. Veenstra, R. N. Hoover, and R. G. Ziegler
Comparison of Liquid Chromatography-Tandem Mass Spectrometry, RIA, and ELISA Methods for Measurement of Urinary Estrogens
Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 292 - 300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. A. O'Connor, R. J. Ferrell, E. Brindle, J. Shofer, D. J. Holman, R. C. Miller, D. E. Schechter, B. Singer, and M. Weinstein
Total and Unopposed Estrogen Exposure across Stages of the Transition to Menopause
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 828 - 836.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Faupel-Badger, C.-C. Hsieh, R. Troisi, P. Lagiou, and N. Potischman
Plasma Volume Expansion in Pregnancy: Implications for Biomarkers in Population Studies
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1720 - 1723.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. E. Wood, T. C. Register, and J.M. Cline
Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys
Carcinogenesis, April 1, 2007; 28(4): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
W.-H. Wu, L.-Y. Liu, C.-J. Chung, H.-J. Jou, and T.-A. Wang
Estrogenic Effect of Yam Ingestion in Healthy Postmenopausal Women
J. Am. Coll. Nutr., August 1, 2005; 24(4): 235 - 243.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Falk, T. R. Fears, X. Xu, R. N. Hoover, M. C. Pike, A. H. Wu, A. M.Y. Nomura, L. N. Kolonel, D. W. West, D. W. Sepkovic, et al.
Urinary Estrogen Metabolites and Their Ratio among Asian American Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Yu, C. H. Lee, P. H. Tan, and P. Tan
Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations
Clin. Cancer Res., August 15, 2004; 10(16): 5508 - 5517.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Santoro, B. Lasley, D. McConnell, J. Allsworth, S. Crawford, E. B. Gold, J. S. Finkelstein, G. A. Greendale, J. Kelsey, S. Korenman, et al.
Body Size and Ethnicity Are Associated with Menstrual Cycle Alterations in Women in the Early Menopausal Transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2622 - 2631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. E Kasim-Karakas, R. U Almario, L. Gregory, H. Todd, R. Wong, and B. L Lasley
Effects of prune consumption on the ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone
Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1422 - 1427.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
E. Yared, T. J. McMillan, and F. L. Martin
Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay
Mutagenesis, July 1, 2002; 17(4): 345 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Brown, L. Cheng, S. Lin, and D. T. Baird
Daily Low-Dose Mifepristone Has Contraceptive Potential by Suppressing Ovulation and Menstruation: A Double-Blind Randomized Control Trial of 2 and 5 mg per Day for 120 Days
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 63 - 70.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.